000 | 01924 a2200553 4500 | ||
---|---|---|---|
005 | 20250515161321.0 | ||
264 | 0 | _c20090623 | |
008 | 200906s 0 0 eng d | ||
022 | _a1530-9932 | ||
024 | 7 |
_a10.1208/s12249-009-9192-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMahmoud, Enas A | |
245 | 0 | 0 |
_aPreparation and evaluation of self-nanoemulsifying tablets of carvedilol. _h[electronic resource] |
260 |
_bAAPS PharmSciTech _c2009 |
||
300 |
_a183-92 p. _bdigital |
||
500 | _aPublication Type: Evaluation Study; Journal Article | ||
650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B |
650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xantagonists & inhibitors |
650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xchemistry |
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xmetabolism |
650 | 0 | 4 |
_aCarbazoles _xchemistry |
650 | 0 | 4 | _aCarvedilol |
650 | 0 | 4 |
_aCastor Oil _xanalogs & derivatives |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 | _aChemistry, Pharmaceutical |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Carriers |
650 | 0 | 4 | _aDrug Compounding |
650 | 0 | 4 | _aEmulsions |
650 | 0 | 4 |
_aEthylene Glycols _xchemistry |
650 | 0 | 4 |
_aExcipients _xchemistry |
650 | 0 | 4 | _aHCT116 Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInhibitory Concentration 50 |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 | _aNanoparticles |
650 | 0 | 4 |
_aPaclitaxel _xmetabolism |
650 | 0 | 4 | _aPowders |
650 | 0 | 4 |
_aPropanolamines _xchemistry |
650 | 0 | 4 |
_aSilicon Dioxide _xchemistry |
650 | 0 | 4 | _aSolubility |
650 | 0 | 4 | _aTablets |
650 | 0 | 4 |
_aTechnology, Pharmaceutical _xmethods |
650 | 0 | 4 |
_aTriglycerides _xchemistry |
700 | 1 | _aBendas, Ehab R | |
700 | 1 | _aMohamed, Magdy I | |
773 | 0 |
_tAAPS PharmSciTech _gvol. 10 _gno. 1 _gp. 183-92 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1208/s12249-009-9192-7 _zAvailable from publisher's website |
999 |
_c18680669 _d18680669 |